Leading Agricultural Institute Reports Robust Genetic Analysis Results from Fluidigm Biomark™ System
News Jul 22, 2010
Fluidigm Corporation has announced that the Toulouse Midi-Pyrénées Genomic Platform - Genotoul INRA core facility is now providing a wide range of services on a BioMark™ System for Genetic Analysis to a diverse range of French researchers. These services include SNP genotyping, gene expression analysis and digital PCR quantification of DNA libraries for next-generation sequencing. The INRA has been validating the performance of the system on several projects over the past year.
"We have used the BioMark system for many different applications and have found the results to be very robust and comparable to those obtained using classical techniques. However, this platform allows us to provide researchers with a lot more high-quality data, in a fraction of the time, at a very affordable cost. In addition, we were the first facility to offer Fluidigm technology in France and are delighted that we are seeing the demand for this technology increasing nicely," said Denis Milan, group leader of the Department of Animal Genetics at INRA.
The INRA Genomic Platform core facility offers researchers access to the world's most-advanced life science tools through the organization's service center, which is also open to scientists from other institutes. Many species, such as human, pig, mouse, rat, chicken, Macaque, and many more, have been studied at this facility.
"We are delighted and honored that INRA is using our BioMark System and Fluidigm chips to bring gene expression, genotyping and digital PCR capabilities to European researchers. Having an organization with the worldwide reputation of the Genotoul INRA core facility (National Institute of Agricultural Research) capitalizing on the versatility and capabilities of our integrated fluidic circuit (IFC) technology affords Fluidigm a great opportunity to demonstrate how much value we can bring to a wide range of research," said Gajus Worthington, president and chief executive officer, Fluidigm.
Fluidigm's BioMark system is a high-throughput, high-performance genetic analysis platform. It can enable a variety of applications, including disease tissue profiling, single cell gene expression, ultra-high throughput genotyping, and absolute quantitation via digital PCR.